Evaluating Weight Loss Outcomes in Patients With Overweight or Obesity
NCT07551193 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2026-04-24
Summary
The goal of this observational study is to evaluate weight loss outcomes in adults with overweight or obesity using weight management medications. The main questions it aims to answer are: (1) How much weight do patients lose after 12 months? (2) Do blood sugar and cholesterol levels improve? (3) How safe and tolerable are these medications? This is a retrospective study using existing medical records and pharmacy claims. Participants will not be asked to do anything new; all data will be collected from routine clinical care.
Conditions
- Overweight and Obesity
Sponsors & Collaborators
-
Aldafter Medical Center, Bahrain
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-25
- Primary Completion
- 2026-06-25
- Completion
- 2026-10-30
Countries
- Bahrain
Study Locations
More Related Trials
-
Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects
NCT00909766 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
NCT07232719 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects
NCT01719419 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Test Different Doses of BI 456906 in Patients With Obesity
NCT03591718 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity
NCT03479892 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
NCT07184632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Weight Loss With Exenatide Treatment
NCT01590433 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity
NCT07400679 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY
NCT04616339 ·Status: COMPLETED ·Phase: PHASE1
-
Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
NCT03534310 ·Status: COMPLETED ·Phase: NA
-
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
NCT05564117 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
NCT07055516 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults
NCT07513168 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Pharmacotherapy With GLP-1 and GIP/GLP-1 Analogs on Changes in Qualitative and Quantitative Parameters of the Diet as Well as Metabolic and Behavioral Parameters in Patients With Excess Body Weight
NCT07270497 ·Status: RECRUITING
-
Efficacy and Safety of ATL-962 in Obese Diabetics
NCT00156897 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
NCT03661879 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.
NCT06856928 ·Status: NOT_YET_RECRUITING
-
A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
NCT04102189 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity
NCT06579092 ·Status: COMPLETED ·Phase: PHASE2
-
A Multidisciplinary Weight Loss Program at AUB-MC
NCT04194424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
NCT05035095 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)
NCT00109148 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
NCT06501326 ·Status: RECRUITING ·Phase: PHASE4
-
An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity
NCT01096979 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
NCT03308721 ·Status: COMPLETED ·Phase: PHASE1